B. Norris

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

Mark N. Levine, V. Bramwell, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 1998 · 622 citations

Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer

Ivo A. Olivotto, Chris Bajdik, Peter M. Ravdin et al. · Journal of Clinical Oncology · 2005 · 571 citations · Full text

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

Stephen Chia, B. Norris, Caroline Speers et al. · Journal of Clinical Oncology · 2008 · 299 citations · Full text

Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163

Susan Ellard, Mark Clemons, Karen A. Gelmon et al. · Journal of Clinical Oncology · 2009 · 260 citations

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand et al. · Cancer · 1990 · 207 citations · Full text

Eighty-seven Patients, Pancreatic Cancer, Gastrointestinal Oncology +12